Sign Up to like & get
recommendations!
1
Published in 2019 at "Advanced materials"
DOI: 10.1002/adma.201807275
Abstract: All-polymer solar cells (all-PSCs) based on n- and p-type polymers have emerged as promising alternatives to fullerene-based solar cells due to their unique advantages such as good chemical and electronic adjustability, and better thermal and…
read more here.
Keywords:
type polymers;
pscs;
solar cells;
advances type ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Chemical Society reviews"
DOI: 10.1039/d2cs00720g
Abstract: Organic semiconductors have received broad attention and research interest due to their unique integration of semiconducting properties with structural tunability, intrinsic flexibiltiy and low cost. In order to meet the requirements of organic electronic devices…
read more here.
Keywords:
ambipolar organic;
multi functional;
organic semiconductors;
advances type ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Current medicinal chemistry"
DOI: 10.2174/0929867329666220825161603
Abstract: In the last decade, selective modulators of type-2 cannabinoid receptor (CB2) have become a major focus to target endocannabinoid signaling in humans. Indeed, heterogeneously expressed within our body, CB2 actively regulates several physio-pathological processes, thus…
read more here.
Keywords:
cb2 agonists;
type cannabinoid;
cb2;
advances type ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1213417
Abstract: COPYRIGHT © 2023 Bleich. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s)…
read more here.
Keywords:
diabetes research;
advances type;
21st century;
century advances ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Medical Journal of Australia"
DOI: 10.5694/mja2.50472
Abstract: Treatment options for type 2 diabetes have expanded. While metformin remains the first line treatment in most cases, choices for second line treatment now extend beyond sulfonylureas and include the sodium–glucose cotransporter 2 (SGLT2) inhibitors,…
read more here.
Keywords:
therapy focus;
focus cardiovascular;
diabetes therapy;
cardiovascular renal ... See more keywords